ClinicalTrials.gg
Status unknownNCT04862494PedDiaVenUpdated Apr 28, 2021

Diaphragmatic Eventration in Children : Evaluation of Care Strategies and Results in the French Cohort.

An observational study in Diaphragmatic Eventration, sponsored by University Hospital, Angers. Status unknown. Open to participants aged Up to 16 Years. Per ClinicalTrials.gov, last updated 2021-04-28.

Sponsored by University Hospital, Angers · Observational

The sponsor has not verified this record recently (last verified Apr 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Ages
Up to 16 Years
Sex
All
01

Study summary

A diaphragmatic eventration is an abnormal and permanent elevation of a portion or an entire intact hemidiaphragm. This rare pathology, found in 0.2 - 1 for every 1000 patients in large radiological series, is either congenital or acquired due to phrenic nerve palsy.

Most diaphragmatic eventrations are asymptomatic and discovered thanks to chest x-rays, where the diaphragmatic dome is elevated and visualized above the 4th intercostal space and sometimes up to the clavicle. Computed tomography or magnetic resonance imaging confirms the eventration by visualizing the diaphragmatic muscle distended and intact, unlike a diaphragmatic rupture or hernia.

Surgical indications are usually due to respiratory disorders or visceral repercussions, such as gastric emptying disorders or acute accidents like gastric volvulus. Surgical treatment is a phrenic plication, which can be performed via a lateral thoracotomy (classical approach), thoracoscopy or laparoscopy.

When surgery is not indicated, follow up consists of regular clinical and radiological monitoring.

There is, however, no consensus when it comes to their medical and surgical management due to the very low number of patients per center and per year, and the fact that very few studies specifically address this subject in the literature.

Read the detailed description

This is a retrospective multicenter descriptive cohort study based on French national healthcare data. The aim of this study is to describe the current trends in management of diaphragmatic eventrations in France in order to indentify potential risk factors for complications and to improve and homogenize practices.

02

Conditions studied

  • Diaphragmatic Eventration

Keywords

  • thoracoscopy
  • laparoscopy
  • digestive disorders
  • restrictive syndrom
03

In context

Digestive System Diseases

406 studies on the registry are indexed under Digestive System Diseases; 79 are open to participants now.

This study's planned enrollment of 100 is below the median of 400 across 105 observational studies indexed under Digestive System Diseases.

Browse Digestive System Diseases studies →

Lead sponsor

University Hospital, Angers is the lead sponsor of 478 studies on the registry; 120 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

National cohort of all pediatric patients diagnosed with or operated for diaphragmatic eventration since January, 1st, 2010, in a pediatric surgical care unit in France. Patients will be devided into non operated and operated patients for outcome comparisons.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients of 16 years of age and under at diagnosis with diaphragmatic eventration, treated since 2010 in a pediatric surgery care unit in France.

Exclusion criteria

Exclusion Criterion:

  • Patients with a diaphragmatic hernia
  • Patient's parents or legual guardian opposed to being included in the study.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • diaphragmatic eventation with medical surveillance

    Patients with a diagnosis of diaphragmatic eventration without respiratory or digestive consequences, thus not requiring surgical repair.

    Other: clinical surveillance

  • diaphragmatic eventration treated with plication

    Patients with a diagnosis of diaphragmatic eventration with respiratory or digestive repercussion, requiring surgical repair.

    Procedure: diaphragmatic plication

Interventions

  • Otherclinical surveillance

    regular clinical follow up including chest X-rays, pulmonary investigations, etc...

  • Procedurediaphragmatic plication

    plication of a hemidiaphragm, performed via laparoscopy, thoracoscopy (including robot-assisted surgery), or classical thoracotomy

06

What researchers measure

Primary outcomes

  1. To assess the level of asymptomatic patients diagnosed with diaphragmatic eventration depending on the type of treatment (surgical or not).

    Asymptomatic patient rate defined as patients presenting without any digestive, respiratory or orthopaedic symptom.

    Time frame: Up to 16 years of age. From the date of diagnosis until the date of last check-up, assessed up to 16 years of age

Secondary outcomes

  1. To assess the occurrence of lung disease in patients with non treated diaphragmatic eventrations

    Objectified by pulmonary function tests (PFTs), carried out according to the ATS/ERS-GLI (American Thoracic Society and European Respiratory Society-Global Lung Initiative) recommendations.

    Time frame: Up to 16 years of age. From the date of diagnosis until the date of last check-up, assessed up to 16 years of age

  2. To assess the rate of digestive symptoms in patients with diaphragmatic eventrations.

    Clinical assessment of digestive symptoms linked to diaphragmatic eventration and/or to diaphragmatic plication, such à GERD, dumping syndrom, digestive occlusion or pain (scored by visual analogic scale).

    Time frame: Up to 16 years of age. From the date of diagnosis until the date of last check-up, assessed up to 16 years of age

  3. To assess the occurrence of orthopaedic impact of non treated diaphragmatic eventrations

    objectified by the deformation of the spine on chest x-ray measured by the Cobb angle.

    Time frame: Up to 16 years of age. From the date of diagnosis until the date of last check-up, assessed up to 16 years of age

  4. To assess the severity rate of postoperative complications

    Description of postoperative complications encountered after diaphragmatic plication, scored with the Clavien-Dindo classification.

    Time frame: Up to 16 years of age. From the date of diagnosis until the date of last check-up, assessed up to 16 years of age

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2021; primary completion for Dec 2021, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 12, 2021
First posted
Apr 28, 2021
StartEst.
May 2021
Primary completionEst.
Dec 2021
CompletionEst.
Jun 2022
Last update
Apr 28, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04862494
Responsible party
Sponsor
First posted
Apr 28, 2021
Start date
May 2021 (estimated)
Primary completion
Dec 2021 (estimated)
Completion
Jun 2022 (estimated)
Last update
Apr 28, 2021

Study contacts

Françoise Schmitt, MD-PhD
Contact
FrSchmitt@chu-angers.fr
+33241354290
Guillaume Podevin, MD-PhD
study director · University Hospital of Angers

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion